Toronto, Canada, November 16, 2022 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) would like to report that further to the news release on November 11, 2022, the Company has refiled its financial results for Q1 and Q2 2022 amid the news of the cancellation of its stock options of an aggregated 13,000,000 incentive stock options issued pursuant to the Company’s stock option plan on January 25, 2022.
Datametrex has filed its financial statements and the management discussion and analysis (“MD&A”) on SEDAR. Please refer to the Q1 and Q2 2022 filing in its entirety, which is available under Datametrex’ profile at www.sedar.com.
About Datametrex
Datametrex AI Limited is a technology-focused company using artificial intelligence (AI) to create progressive solutions for the cyber security, telehealth, and electric vehicle (EV) verticals. Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals with predictive and preventive technologies.
For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.
For further information:
Investor Relations & Communications
Priya Monique Atwal, Director of Communications
Email: investors@datametrex.com
Tel: 416-901-5611 x 204
Marshall Gunter, CEO
Email: mgunter@datametrex.com
Tel: 514-295-2300
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.
###
An essay is a brief written composition that examines a particular subject, offering the author's viewpoint and analysis. It typically consists of an introduction, body paragraphs, and a conclusion. Essays are commonly used in educational settings to enhance students' analytical and writing abilities. A strong essay online letter of recommendation service presents a clear thesis statement, structured content, and evidence to support the argument. The introduction introduces the topic, the body paragraphs provide detailed examination or arguments, and the conclusion summarizes the main points. Writing an effective essay demands critical thinking, clear communication, and a systematic approach to organizing thoughts.
Need inspiration for your nursing essay? Visit https://nursingwriting.org/nursing-essay-topics/ for a list of expertly curated topics. Our service offers original papers written from scratch by qualified writers with RN, MSN, and DNP degrees. We guarantee fast delivery, adherence to instructions, and unlimited revisions. Enhance your writing and achieve top grades with our professional assistance!